Skip to content
CTD // Fund

D3

Venture capital fund investing in early-stage healthtech startups

← Fund directory

D3

Japan

D3 is an institutional investor (Healthcare Startups) founded in 2017 and headquartered in Tokyo, Japan. Venture capital fund investing in early-stage healthtech startups. Invests in biotech and digital healthcare start-ups with the potential to contribute to global health. As an institutional investor, the firm manages capital on behalf of institutional limited partners, deploying capital across selected investment opportunities with strong growth potential.

Stage
pre-seed, seed, follow-on, pre-seed, seed, follow-on
Check size
$500K-$1.5M initial
HQ
Tokyo, Japan
Founded
2017
Website
https://www.d3growth.com
LinkedIn
https://linkedin.com/company/newton-biocapital-fund
Institutional Investordefense techdronesEW/RFautonomysensorsAImission systemsdeminingnational security

What they look for

early-stage deep tech startups from Ukraine and allies; full-time core team with mandatory technical co-founders; scalable R&D/production; product validated for end-customers esp. Ukraine army; background check

Related startups

RefaceAI

RefaceAI develops AI-enabled face-swapping video editing technology that allows users to replace faces in videos, images, and GIFs with their own photos.

Native AI · Ukraine

HyperVerge

Thirddimension.ai is a developer of a spatial generation platform for creating high-fidelity 3D worlds and simulations.

Native AI · Bengaluru, India

Gravitics

Gravitics develops space infrastructure platforms providing real estate, logistics, and power in orbit for commercial, civil, and defense applications.

Aerospace, Maritime and Defense Tech · Seattle, United States

📊 Revenue multiples by stage & sector — free comps-based startup valuation calculator.

⚠️ Common pitch mistakes we see →

Preparing to pitch D3?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →